Document is current

Any future updates will be listed below

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'

Crossref DOI link: https://doi.org/10.1186/S13075-014-0434-Z

Published: 2014-10

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark